DNA损伤
生物
转录因子
细胞周期
细胞生物学
DNA修复
癌症研究
人口
细胞
DNA
遗传学
基因
医学
环境卫生
作者
Harald Schuhwerk,Julia Kleemann,Pooja Gupta,Ruthger van Roey,Isabell Armstark,Martina Kreileder,Nora Feldker,Vignesh Ramesh,Yussuf Hajjaj,Kathrin Fuchs,Mousumi Mahapatro,Mojca Hriberšek,Marco Volante,Arwin Groenewoud,Felix Benedikt Engel,Paolo Ceppi,Markus Eckstein,Arndt Hartmann,Fabian Müller,Torsten C. Kroll
出处
期刊:Cell Reports
[Cell Press]
日期:2022-12-01
卷期号:41 (11): 111819-111819
被引量:25
标识
DOI:10.1016/j.celrep.2022.111819
摘要
The DNA damage response (DDR) and epithelial-to-mesenchymal transition (EMT) are two crucial cellular programs in cancer biology. While the DDR orchestrates cell-cycle progression, DNA repair, and cell death, EMT promotes invasiveness, cellular plasticity, and intratumor heterogeneity. Therapeutic targeting of EMT transcription factors, such as ZEB1, remains challenging, but tumor-promoting DDR alterations elicit specific vulnerabilities. Using multi-omics, inhibitors, and high-content microscopy, we discover a chemoresistant ZEB1-high-expressing sub-population (ZEB1 hi ) with co-rewired cell-cycle progression and proficient DDR across tumor entities. ZEB1 stimulates accelerated S-phase entry via CDK6, inflicting endogenous DNA replication stress. However, DDR buildups involving constitutive MRE11-dependent fork resection allow homeostatic cycling and enrichment of ZEB1 hi cells during transforming growth factor β (TGF-β)-induced EMT and chemotherapy. Thus, ZEB1 promotes G1/S transition to launch a progressive DDR benefitting stress tolerance, which concurrently manifests a targetable vulnerability in chemoresistant ZEB1 hi cells. Our study thus highlights the translationally relevant intercept of the DDR and EMT.
科研通智能强力驱动
Strongly Powered by AbleSci AI